Risk stratification in early-stage Cardiovascular-Kidney-Metabolic Syndrome: The Potency of visceral adiposity and insulin resistance surrogate indices
Authors:
- 24 May 2026
- journal article
- review article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 237, 113336
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82200390)
This publication has 50 references indexed in Scilit:
- A Systematic Review of Artificial Intelligence Models for Time-to-Event Outcome Applied in Cardiovascular Disease Risk PredictionJournal of Medical Systems, 2024
- Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020JAMA, 2024
- Emerging Mechanisms and Disease Relevance of FerroptosisTrends in Cell Biology, 2020
- Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic healthClinical Nutrition, 2020
- Uncoupling protein 1 inhibits mitochondrial reactive oxygen species generation and alleviates acute kidney injuryEBioMedicine, 2019
- Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statementThe Lancet Diabetes & Endocrinology, 2019
- Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in HumansCell Metabolism, 2017
- Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patientsMetabolism, 2016
- Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical modelObesity, 2013
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004